| pubmed-article:18468388 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0006836 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0003308 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0025664 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0002679 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0016277 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0370215 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C1697858 | lld:lifeskim |
| pubmed-article:18468388 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:18468388 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18468388 | pubmed:dateCreated | 2008-5-12 | lld:pubmed |
| pubmed-article:18468388 | pubmed:abstractText | This study analyzed the correlation between the results obtained through two microdilution methods: Clinical and Laboratory Standard Institute (CLSI) (M27-A2) and European Committee on Antibiotic Susceptibility Testing (EUCAST) (document E. Dis. 7.1) and an agar base method Etest for determining minimmun inhibitory concentration (MIC) for amphotericin B and fluconazole against 30 clinical isolates of Candida spp. The agreement between Etest, CLSI and EUCAST MICs within +/- 2 log2 dilutions was higher for amphotericin B than for fluconazole However, Pearson correlation demonstrated a greater agreement for fluconazole. The categorical agreement between MICs provided by the Etest/ CLSI and Etest/EUCAST methodologies was high for both amphotericin B (100%) and fluconazole (> or = 96.66%). This study demonstrated the adequacy of Etest method using Mueller Hinton agar to evaluate amphotericin B and fluconazole susceptibility of clinical isolates of Candida spp. | lld:pubmed |
| pubmed-article:18468388 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18468388 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18468388 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18468388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18468388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18468388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18468388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18468388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18468388 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18468388 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:18468388 | pubmed:issn | 0031-7144 | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:LyonJ PJP | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:FrancoM CMC | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:ChavascoJ KJK | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:SzeszsM WMW | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:MelhemM S CMS | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:ClaudinoA L... | lld:pubmed |
| pubmed-article:18468388 | pubmed:author | pubmed-author:PeixotoR... | lld:pubmed |
| pubmed-article:18468388 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18468388 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:18468388 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18468388 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18468388 | pubmed:pagination | 286-9 | lld:pubmed |
| pubmed-article:18468388 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:meshHeading | pubmed-meshheading:18468388... | lld:pubmed |
| pubmed-article:18468388 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18468388 | pubmed:articleTitle | Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates. | lld:pubmed |
| pubmed-article:18468388 | pubmed:affiliation | Departamento de Ciências Biológicas, Universidade Federal de Alfena (UNIFAL-MG), Alfenas-MG, Brazil. | lld:pubmed |
| pubmed-article:18468388 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18468388 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:18468388 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
